Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04866472 · ClinicalTrials.gov registry record · NA
Comparison Using a VLS Using GlideRite Stylet Versus TCI Articulating Introducer in Predictive Difficult Intubation
A NA study of Predicted Difficult Airway, sponsored by University of Louisville.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 2
- Study locations
NCT04866472: Recruiting NA study of Predicted Difficult Airway, sponsored by University of Louisville.
NCT04866472 is a NA study of Predicted Difficult Airway that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04866472, a NA study of Predicted Difficult Airway, is actively recruiting participants, sponsored by University of Louisville.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will assess the feasibility of using the TCI Articulating Device with video-laryngoscope in predictive, difficult airway, endotracheal intubation cases. It is meant to show the use of this device is equivalent to using the GlideRite Rigid Stylet with video-laryngoscope.
Primary Outcome
successful intubation
Conditions Studied
Interventions
- DEVICE video-laryngoscope and GlideRite Rigid Stylet
- DEVICE video-laryngoscope and TCI Articulating Introducer Device
Study Locations (2)
Kentucky
- University of Louisville School of Medicine - Louisville
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2022-04-26 |
| Est. Completion | 2027-04 |
| Phase | NA |
What NCT04866472 shows while recruiting
NCT04866472 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Predicted Difficult Airway appearing as the primary indexed condition, and to 2 interventions - of which video-laryngoscope and GlideRite Rigid Stylet is the first listed.
NCT04866472 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT04866472 about?
NCT04866472 is a clinical study titled "Comparison Using a VLS Using GlideRite Stylet Versus TCI Articulating Introducer in Predictive Difficult Intubation". This study will assess the feasibility of using the TCI Articulating Device with video-laryngoscope in predictive, difficult airway, endotracheal intubation cases. It is meant to show the use of this device is equivalent to using the GlideRite Rigid Stylet with video-laryngoscope.
What is the current status of trial NCT04866472?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2022-04-26. Estimated completion is 2027-04.
What conditions does trial NCT04866472 study?
This clinical trial studies the following conditions: Predicted Difficult Airway.
What interventions are being tested in trial NCT04866472?
The interventions under investigation include: video-laryngoscope and GlideRite Rigid Stylet (DEVICE), video-laryngoscope and TCI Articulating Introducer Device (DEVICE).
Who is sponsoring clinical trial NCT04866472?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04866472 being conducted?
This trial has 2 study locations across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04866472's enrollment target sits among peer trials
160 628th of 2000 higher than 1,348 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI